Sponsor:
National Cancer Institute (NCI)
Code:
NCT04923178
Conditions
Urothelial Cancer
Bladder Cancer
Genitourinary Cancer
Urogenital Neoplasms
Urogenital Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Brief summary:
Conditions
Urothelial Cancer
Bladder Cancer
Genitourinary Cancer
Urogenital Neoplasms
Urogenital Cancer
Study ID
NCT04923178
Start date
Oct 24, 2022
Status verified date
Aug 6, 2026
Completion date
Dec 1, 2042
Anticipated
Primary completion date
Dec 1, 2041
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
1100 participants
Anticipated
Arms
1 / Urothelial cancer
2 / Rare Bladder or Urinary Tract Histology
3 / Urothelial Carcinoma Variants
4 / Rare GU Tumors
Primary outcome measure
Central contacts
Locations
National Institutes of Health Clinical Center
Recruiting
Bethesda, Maryland, United States, 20892
Contacts
For more information at the NIH Clinical Center contact National Cancer Institute Referral Office
888-624-1937Sponsor
National Cancer Institute (NCI)
Last update posted
Aug 10, 2026
Last verified
Aug 6, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by National Cancer Institute (NCI) on 2026-08-10.